Ideas & Insights

If you’re thinking of taking your company public, consider these five advantages and five disadvantages of an IPO first

Loss corporations that have appreciated in value at the time of an ownership change may be able to treat a portion of their GILTI as RBIG.

Your company’s path to initial public offering is complex and requires significant time to plan and execute to success.

The road to IPO for life sciences companies is complex and requires significant time to plan and execute to ensure success. Are you ready?

Pharmaceutical, biotech and medical device company finance leaders discuss ASC 842 lease accounting adoption complexities and challenges.

What are key drivers for going public and how should life sciences companies prepare for their initial public offering? We share insights in this ...

How can life sciences companies looking to go public position themselves for success? It’s all about setting the stage early on.

Informa Connect’s Finance and Accounting for Bioscience Companies East will be a HYBRID event, combining live and digital.

Understanding the impact and the significance of the upcoming changes on Life Sciences companies and tax policies.

We able to gather again in person, at the Hyatt Regency in New Brunswick, N.J. for the 26th annual Medicaid Drug Rebate Program conference

What can life sciences businesses do to ensure data protection, especially with their third parties? Get key cybersecurity considerations.

Learn how outsourcing can help life sciences organization establish a strong foundation for current and sustained success.

Companies abandoning plans for IPO or SPAC transactions should consider the deductibility of transaction costs and termination fees.

Whether pharma, biotech or medical device business, learn the five key questions you should consider now as you begin your IPO journey.

RSM’s life sciences industry insider shares key insights and benefits of conducting a third-party contract compliance audit.

Learn how life sciences companies leverage finance & accounting outsourcing to enhance the finance function and focus on core competencies.

Issues to consider when incorporating a partnership to benefit from the qualified small business stock exclusion

Third parties provide a vital business partnership for growing life sciences companies, but there are risks to consider.

Life sciences companies, learn how you can get the most out of your outsourcing relationships and keep your focus on the science

Build your foundation of understanding about the complexities of VAT and GST and the impact they can have on U.S. multinational businesses.